Clinical Trial Update: The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy of subconjunctival bevacizumab for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Neon Hospital | Conditions: Diabetic Macular Edema | NA | Status: COMPLETED